• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2020 o Market outlook: Forecast for 2020 - 2025 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Type o Market segments o Comparison by Type o Primary Sjogren's syndrome - Market size and forecast 2020-2025 o Secondary Sjogren's syndrome - Market size and forecast 2020-2025 o Market opportunity by Type • Customer Landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2020-2025 o Europe - Market size and forecast 2020-2025 o Asia - Market size and forecast 2020-2025 o ROW - Market size and forecast 2020-2025 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Overview o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o AbbVie Inc. o ADVANZ PHARMA Corp. Ltd. o Biogen Inc. o Bristol-Myers Squibb Co. o Daiichi Sankyo Co. Ltd. o Hikma Pharmaceuticals Plc o Johnson & Johnson o Novartis AG o Sanofi SA o Sun Pharmaceutical Industries Ltd. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2020 - 2025 ($ million) • 13: Global market: Year-over-year growth 2020 - 2025 (%) • 14: Five forces analysis 2020 & 2025 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2020 • 21: Customer landscape • 22: Impact of drivers and challenges • 23: Vendor landscape • 24: Landscape disruption • 25: Industry risks • 26: Vendors covered • 27: Market positioning of vendors • 28: AbbVie Inc. - Overview • 29: AbbVie Inc. - Business segments • 30: AbbVie Inc. - Key offerings • 31: AbbVie Inc. - Key customers • 32: AbbVie Inc. - Segment focus • 33: ADVANZ PHARMA Corp. Ltd. - Overview • 34: ADVANZ PHARMA Corp. Ltd. - Business segments • 35: ADVANZ PHARMA Corp. Ltd. - Key offerings • 36: ADVANZ PHARMA Corp. Ltd. - Key customers • 37: ADVANZ PHARMA Corp. Ltd. - Segment focus • 38: Biogen Inc. - Overview • 39: Biogen Inc. - Business segments • 40: Biogen Inc. - Key offerings • 41: Biogen Inc. - Key customers • 42: Biogen Inc. - Segment focus • 43: Bristol-Myers Squibb Co. - Overview • 44: Bristol-Myers Squibb Co. - Product and service • 45: Bristol-Myers Squibb Co. - Key offerings • 46: Bristol-Myers Squibb Co. - Key customers • 47: Bristol-Myers Squibb Co. - Segment focus • 48: Daiichi Sankyo Co. Ltd. - Overview • 49: Daiichi Sankyo Co. Ltd. - Business segments • 50: Daiichi Sankyo Co. Ltd. - Key offerings • 51: Daiichi Sankyo Co. Ltd. - Key customers • 52: Daiichi Sankyo Co. Ltd. - Segment focus • 53: Hikma Pharmaceuticals Plc - Overview • 54: Hikma Pharmaceuticals Plc - Business segments • 55: Hikma Pharmaceuticals Plc - Key offerings • 56: Hikma Pharmaceuticals Plc - Key customers • 57: Hikma Pharmaceuticals Plc - Segment focus • 58: Johnson & Johnson - Overview • 59: Johnson & Johnson - Business segments • 60: Johnson & Johnson - Key offerings • 61: Johnson & Johnson - Key customers • 62: Johnson & Johnson - Segment focus • 63: Novartis AG - Overview • 64: Novartis AG - Business segments • 65: Novartis AG - Key offerings • 66: Novartis AG - Key customers • 67: Novartis AG - Segment focus • 68: Sanofi SA - Overview • 69: Sanofi SA - Business segments • 70: Sanofi SA - Key offerings • 71: Sanofi SA - Key customers • 72: Sanofi SA - Segment focus • 73: Sun Pharmaceutical Industries Ltd. - Overview • 74: Sun Pharmaceutical Industries Ltd. - Business segments • 75: Sun Pharmaceutical Industries Ltd. - Key offerings • 76: Sun Pharmaceutical Industries Ltd. - Key customers • 77: Sun Pharmaceutical Industries Ltd. - Segment focus • 78: Currency conversion rates for US$ • 79: Research Methodology • 80: Validation techniques employed for market sizing • 81: Information sources • 82: List of abbreviations

AbbVie Inc., ADVANZ PHARMA Corp. Ltd., Biogen Inc., Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., Hikma Pharmaceuticals Plc, Johnson & Johnson, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd.